Valuation: Vitrolife AB

Market Cap 11.59B 1.19B 1.04B 969M 891M 1.67B 115B 1.7B 4.52B 56.01B 4.45B 4.36B 194B P/E 2026 *
23.5x
P/E 2027 * 19x
Enterprise Value 12.13B 1.24B 1.09B 1.01B 933M 1.75B 120B 1.78B 4.73B 58.66B 4.66B 4.56B 204B EV / Sales 2026 *
3.52x
EV / Sales 2027 * 3.12x
Free-Float
54.39%
Yield 2026 *
1.29%
Yield 2027 * 1.47%
1 day-3.22%
1 week-11.39%
Current month-2.51%
1 month-2.23%
3 months-28.65%
6 months-31.17%
Current year-37.55%
1 week 85.55
Extreme 85.55
93
1 month 84.85
Extreme 84.85
101.9
Current year 84.6
Extreme 84.6
139.6
1 year 84.6
Extreme 84.6
153.5
3 years 84.6
Extreme 84.6
268
5 years 84.6
Extreme 84.6
585
10 years 70
Extreme 70
585
Manager TitleAgeSince
Chief Executive Officer 52 01/08/2023
Director of Finance/CFO 55 10/10/2025
Chief Investment Officer 39 -
Director TitleAgeSince
Director/Board Member 63 19/04/2013
Chairman 70 01/08/2023
Chairman 55 -
Date Insider Type Main position Quantity % Market Cap.
2/6/26 A Buy

Chief Operating Officer

6,470 0.0048%
2/6/26 A Buy

Chief Executive Officer

3,013 0.0022%
2/4/26 A Buy

Chief Financial Officer

2,200 0.0016%
Change 5-day change 1-year change 3-year change Capi.($)
-3.22%-11.39%-40.92%-49.08% 1.24B
-0.36%-3.10%+230.47%+298.83% 19.99B
-1.22%-5.09%-43.44%-27.84% 9.4B
-0.84%-1.31%+41.50%+18.49% 6.81B
+2.15%+8.05%+252.86%-19.85% 5.97B
-1.59%+5.91%-12.16%-23.02% 5.62B
-10.00%+2.06%+88.80%+110.73% 5.06B
+1.76%-5.04%-47.89% - 4.35B
0.00%-4.24%-26.67%-28.44% 4.05B
-1.68%-2.81%-16.61%-39.76% 2.76B
Average -1.50%-1.58%+42.59%+26.67% 6.52B
Weighted average by Cap. -1.10%-2.18%+91.33%+96.28%

Financials

2026 *2027 *
Net sales 3.45B 353M 311M 289M 265M 498M 34.21B 507M 1.35B 16.68B 1.33B 1.3B 57.88B 3.71B 379M 334M 310M 285M 535M 36.75B 544M 1.45B 17.92B 1.42B 1.39B 62.18B
Net income 493M 50.41M 44.33M 41.19M 37.88M 71.04M 4.88B 72.31M 192M 2.38B 189M 185M 8.26B 609M 62.31M 54.8M 50.91M 46.82M 87.8M 6.03B 89.38M 237M 2.94B 234M 229M 10.21B
Net Debt 549M 56.2M 49.42M 45.91M 42.23M 79.19M 5.44B 80.61M 214M 2.65B 211M 206M 9.21B -26.74M -2.74M -2.41M -2.24M -2.06M -3.86M -265M -3.93M -10.43M -129M -10.27M -10.05M -448M
Logo Vitrolife AB
Vitrolife AB is a Sweden-based company engaged in assisted reproduction services. The Company’s product portfolio comprises G-RINSE, which is a solution for rinsing of contact materials, EmbryoGlue, which is a human albumin recombinant, ASP, which is a solution for oocyte retrieval and rinsing, and Semen VTS, which is a viscosity treatment system, among others. It also provides a range of procedural solutions for sperm preparation, vitrification, embryo transfer and oocyte retrieval, such as temperature control, condition control, gamete-safe labware and embryo support. The Company is active in Australia, China, France, Italy, Japan, the United States and the United Kingdom, among others, and conducts its business through a number of subsidiaries, such as Vitrolife Ltd., Vitrolife Pty Ltd., and A.T.S. Srl.
Employees
1,103
Date Price Change Volume
23/07/26 SEK 85.55 -3.22% 174,313
22/07/26 SEK 88.40 -0.28% 213,365
21/07/26 SEK 88.65 -1.39% 238,969
20/07/26 SEK 89.90 -2.60% 136,103
17/07/26 SEK 92.30 -4.40% 242,419
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
85.55SEK
Average target price
129.60SEK
Spread / Average Target
+51.49%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. VITR Stock